New Diabetes Drug

The new diabetes drug Dorzagliatin Tablets were approved by the State Food and Drug Administration on Saturday, becoming another world's leading new drug born in Shanghai.

Dorzagliatin is the first glucokinase activator drug approved and marketed worldwide for the treatment of adult type 2 diabetes.

It can reshape the blood glucose homeostasis of the human body and has the potential to relieve diabetes from the source.

It is understood that Shanghai has approved 3 Class I domestic innovative drugs this year.